Methylated urolithin A, mitigates cognitive impairment by inhibiting NLRP3 inflammasome and ameliorating mitochondrial dysfunction in aging mice
Authors:
- 16 April 2024
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 252, 109950
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Neuromodulatory effect of vardenafil on aluminium chloride/d-galactose induced Alzheimer’s disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 pathway, endoplasmic reticulum stress, and cellular senescenceInflammopharmacology, 2023
- Dietary Intervention with the Gut Microbial Metabolite Urolithin A Attenuates Lipopolysaccharide‐Induced Neuroinflammation and Cognitive Deficits via the Sirt1/acetyl‐NF‐κB Signaling PathwayMolecular Nutrition & Food Research, 2023
- Pomegranate polyphenol punicalagin improves learning memory deficits, redox homeostasis, and neuroinflammation in aging micePhytotherapy Research, 2023
- Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s diseaseGeroScience, 2022
- Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut MicrobiotaMolecular Nutrition & Food Research, 2022
- Aging-Dependent Mitophagy Dysfunction in Alzheimer’s DiseaseMolecular Neurobiology, 2021
- Activation of the miR-34a-Mediated SIRT1/mTOR Signaling Pathway by Urolithin A Attenuates d-Galactose-Induced Brain Aging in MiceNeurotherapeutics, 2019
- Neuroinflammation in the central nervous system: Symphony of glial cellsGlia, 2018
- PGC-1α sparks the fire of neuroprotection against neurodegenerative disordersAgeing Research Reviews, 2018
- Nucleolar control of p53: a cellular Achilles’ heel and a target for cancer therapyCellular and Molecular Life Sciences, 2013